The delisting risk is resolved for now, but the caveat about the next periodic report means the next 10-Q or 10-K filing is the key catalyst. Monitor that filing for equity levels and any going-concern language.
Price Chart
Executive Summary
DataMeds AI, Inc. announced it has regained compliance with Nasdaq Listing Rule 5550(b)(1) after receiving a notice from Nasdaq on October 19, 2026. The company had been facing delisting due to negative stockholders' equity of $(12,447,801) as of December 31, 2025, but subsequently demonstrated equity exceeding the $2.5 million minimum. While this removes the immediate delisting risk, the filing warns that failure to evidence compliance upon the next periodic report could lead to delisting.
Key Facts
- DataMeds received a Nasdaq deficiency letter on April 13, 2026 for failing to meet the $2.5 million minimum stockholders' equity requirement (Rule 5550(b)(1)), with equity reported at $(12,447,801) as of Dec 31, 2025.
- On October 19, 2026, Nasdaq confirmed DataMeds regained compliance with Rule 5550(b)(1) after the company filed 8-Ks on Oct 13 and Oct 16, 2026 showing equity exceeded $2.5 million.
- The company had previously regained bid-price compliance on June 9, 2026.
- If DataMeds fails to evidence compliance upon filing its next periodic report, it may be subject to delisting.
Financial Impact
Removal of immediate delisting risk; no financial figures provided beyond the prior equity deficit of $(12,447,801) and the $2.5 million minimum threshold.
Risk Factors
- If the company fails to maintain stockholders' equity above $2.5 million at the next periodic report, it could face delisting proceedings again.
- The company's prior negative equity position suggests ongoing financial fragility; no revenue or earnings data was provided in this filing.
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-047711 |
| Exhibit: ex99-1.htm | 0001493152-26-047711 |
| Document: 0001493152-26-047711-index-headers.html | 0001493152-26-047711 |
| Document: 0001493152-26-047711-index.html | 0001493152-26-047711 |
| Document: 0001493152-26-047711.txt | 0001493152-26-047711 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $2.15 | awaiting T+20 | — | $2.19 (−1.86%) |
Oct 20, 2026 6d ago | 8-K | $2.75 | awaiting T+20 | — | $2.19 (−20.36%) |
Oct 16, 2026 10d ago | 8-K | $2.67 | awaiting T+20 | — | $2.19 (−17.98%) |
Oct 13, 2026 13d ago | 8-K | $2.85 | awaiting T+20 | — | $2.19 (−23.16%) |
Sep 17, 2026 5w ago | 8-K | $3.76 $2.63 | ▼ −30.05% | ▼ −30.26% | $2.19 (−41.76%) |
Sep 16, 2026 5w ago | 8-K | $4.64 $2.85 | ▼ −38.58% | ▼ −39.78% | $2.19 (−52.80%) |
Aug 18, 2026 9w ago | 8-K | $1.38 $6.07 | ▼ −339.86% | ▼ −341.60% | $2.19 (−58.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers